These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

416 related articles for article (PubMed ID: 38669101)

  • 1. The ASAM/AAAP Clinical Practice Guideline on the Management of Stimulant Use Disorder.
    ; ; ;
    J Addict Med; 2024 May-Jun 01; 18(1S Suppl 1):1-56. PubMed ID: 38669101
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Measures of outcome for stimulant trials: ACTTION recommendations and research agenda.
    Kiluk BD; Carroll KM; Duhig A; Falk DE; Kampman K; Lai S; Litten RZ; McCann DJ; Montoya ID; Preston KL; Skolnick P; Weisner C; Woody G; Chandler R; Detke MJ; Dunn K; Dworkin RH; Fertig J; Gewandter J; Moeller FG; Ramey T; Ryan M; Silverman K; Strain EC
    Drug Alcohol Depend; 2016 Jan; 158():1-7. PubMed ID: 26652899
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Commentary on Konstenius et al. (2014): on medication development for stimulant addiction.
    Shoptaw S
    Addiction; 2014 Mar; 109(3):450-1. PubMed ID: 24524320
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of prize-based incentives on outcomes in stimulant abusers in outpatient psychosocial treatment programs: a national drug abuse treatment clinical trials network study.
    Petry NM; Peirce JM; Stitzer ML; Blaine J; Roll JM; Cohen A; Obert J; Killeen T; Saladin ME; Cowell M; Kirby KC; Sterling R; Royer-Malvestuto C; Hamilton J; Booth RE; Macdonald M; Liebert M; Rader L; Burns R; DiMaria J; Copersino M; Stabile PQ; Kolodner K; Li R
    Arch Gen Psychiatry; 2005 Oct; 62(10):1148-56. PubMed ID: 16203960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk of amphetamine use disorder and mortality among incident users of prescribed stimulant medications in the Veterans Administration.
    Westover AN; Nakonezny PA; Halm EA; Adinoff B
    Addiction; 2018 May; 113(5):857-867. PubMed ID: 29215762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Poisoning with central nervous system stimulants. Amphetamine, ecstasy, cocaine and gamma-hydroxybutyrate].
    Christensen HR
    Ugeskr Laeger; 1999 Dec; 161(50):6899. PubMed ID: 10643372
    [No Abstract]   [Full Text] [Related]  

  • 7. Deep brain stimulation for psychostimulant use disorders.
    Swinford-Jackson SE; Pierce RC
    J Neural Transm (Vienna); 2024 May; 131(5):469-473. PubMed ID: 37823965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Stimulant dependence].
    Kishimoto H
    Ryoikibetsu Shokogun Shirizu; 2003; (40):505-6. PubMed ID: 14626171
    [No Abstract]   [Full Text] [Related]  

  • 9. Use of Amphetamine-Type Stimulants Among Emergency Department Patients With Untreated Opioid Use Disorder.
    Chawarski MC; Hawk K; Edelman EJ; O'Connor P; Owens P; Martel S; Coupet E; Whiteside L; Tsui JI; Rothman R; Cowan E; Richardson L; Lyons MS; Fiellin DA; D'Onofrio G
    Ann Emerg Med; 2020 Dec; 76(6):782-787. PubMed ID: 32782084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Do we need clinical trials of high dose stimulant agonist treatment for stimulant use disorders?
    Hall W; Darke S; Farrell M
    Addiction; 2024 Apr; 119(4):786-787. PubMed ID: 38178619
    [No Abstract]   [Full Text] [Related]  

  • 11. [Amphetamine and other stimulants as drugs].
    Holopainen A
    Duodecim; 1998; 114(20):2121-6. PubMed ID: 11717739
    [No Abstract]   [Full Text] [Related]  

  • 12. Nonmedical use of prescription ADHD stimulant medications among adults in a substance abuse treatment population: early findings from the NAVIPPRO surveillance system.
    Cassidy TA; McNaughton EC; Varughese S; Russo L; Zulueta M; Butler SF
    J Atten Disord; 2015 Apr; 19(4):275-83. PubMed ID: 23900405
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of prescription stimulants to enhance academic performance among college students in health care programs.
    Herman L; Shtayermman O; Aksnes B; Anzalone M; Cormerais A; Liodice C
    J Physician Assist Educ; 2011; 22(4):15-22. PubMed ID: 22308929
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [AWMF-guideline: cocaine-, amphetamine-, ecstasy- and hallucinogen-related disorders].
    Thomasius R; Gouzoulis-Mayfrank E; Karus C; Wiedenmann H; Hermle L; Sack PM; Zeichner D; Küstner U; Schindler A; Krüger A; Uhlmann S; Petersen KU; Zapletalova P; Wartberg L; Schütz CG; Schulte-Markwort M; Obrocki J; Heinz A; Schmoldt A;
    Fortschr Neurol Psychiatr; 2004 Dec; 72(12):679-95. PubMed ID: 15580533
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stimulant abuse: pharmacology, cocaine, methamphetamine, treatment, attempts at pharmacotherapy.
    Ciccarone D
    Prim Care; 2011 Mar; 38(1):41-58. PubMed ID: 21356420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The burden and management of crystal meth use.
    Buxton JA; Dove NA
    CMAJ; 2008 Jun; 178(12):1537-9. PubMed ID: 18519899
    [No Abstract]   [Full Text] [Related]  

  • 17. Methamphetamine and psychiatry: A story of the colourless substance of abuse.
    Suetani S; Reddan J; Anderson C
    Australas Psychiatry; 2017 Jun; 25(3):254-256. PubMed ID: 28541728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Misuse of methamphetamine and prescription stimulants among youths and young adults in the community.
    Wu LT; Pilowsky DJ; Schlenger WE; Galvin DM
    Drug Alcohol Depend; 2007 Jul; 89(2-3):195-205. PubMed ID: 17257780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Psychological treatments for stimulant misuse, comparing and contrasting those for amphetamine dependence and those for cocaine dependence.
    Vocci FJ; Montoya ID
    Curr Opin Psychiatry; 2009 May; 22(3):263-8. PubMed ID: 19307968
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Information from your family doctor. Meth abuse: what you should know.
    American Academy of Family Physicians
    Am Fam Physician; 2007 Oct; 76(8):1175-6. PubMed ID: 17990841
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 21.